celltrion vaccine baxter
Scope
Date
~
-
Bio & Pharma
Celltrion wins phase 3 IND approval for Ocrevus biosimilar in US
South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...
Jun 15, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's SK Bioscience to resume domestic flu vaccine output
South Korea's SK Bioscience Co. will resume making domestic flu vaccines by year's end, two years after it stopped production to supply a vaccine fo...
Jun 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand biosimilar portfolio to 11 by 2025
South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it plans to beef up its portfolio by applying for regulatory approv...
Jun 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to develop Humira biosimilar oral medication with US firm
South Korea's biopharmaceutical company Celltrion Inc. announced on Monday that it has signed a contract with the US biotech firm Rani Therapeutics ...
Jun 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Remsima SC praised in Europe as preferred biosimilar
MILAN – South Korea's biopharmaceutical company Celltrion Inc. is known in Europe for its biosimilar products such as autoimmune disease treat...
Jun 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion unveils phase 1 clinical data of Actemra biosimilar in Europe
South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...
May 31, 2023 (Gmt+09:00)
-
Bio & Pharma
BIO USA 2023 to draw S.Korean biotech leaders, startups
More than 500 South Korean companies from top business groups to AI-based biotech startups are slated to attend the Bio International Convention 202...
May 30, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience’s COVID-19 vaccine gets approval in UK
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Monday that its domestic COVID-19 vaccine, SKYCovione, has rec...
May 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Humira biosimilar CT-P17
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...
May 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Cellid applies for Phase 3 clinical trials in S.Korea for COVID-19 vaccine
South Korean bio-venture Cellid Co. announced on Tuesday that it has applied for the clinical Phase 3 trial of the COVID-19 Omicron variant-specific...
May 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches Remsima SC in Brazil
South Korean biopharmaceutical company Celltrion Healthcare Co. revealed on Monday its introduction of Remsima SC, a treatment for autoimmune diseas...
May 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Lemonex signs MOU with WHO mRNA vaccines tech hub
South Korea's gene therapeutics developer Lemonex announced on Tuesday that it has signed a memorandum of understanding (MOU) with the World Health ...
May 09, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion drops bid to acquire Baxter’s biopharm unit
Celltrion Inc. announced on Tuesday it has decided not to pursue the acquisition of the biopharmaceutical unit of U.S. medical device maker Baxter I...
May 09, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience to produce MSD’s new Ebola vaccine candidate
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a contract with MSD, a global pharma...
May 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for Phase 3 clinical trials in Europe for biosimilar
South Korea’s Celltrion Inc. is speeding up global clinical trials of its biosimilar of the multiple sclerosis (MS) treatment Ocrevus (active ...
May 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare enters top 10 in hospital prescriptions in Turkey
South Korean biopharmaceutical company Celltrion Healthcare Co. on Thursday said it ranked in the top 10 out of 400 companies last year on the Turki...
Apr 21, 2023 (Gmt+09:00)
-
Private equity
MBK Partners co-founder tops 50 richest S.Koreans: Forbes
Michael ByungJu Kim, co-founder and partner at private equity firm MBK Partners, has topped the ranking of the 50 richest South Koreans by net worth...
Apr 18, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Celltrion Healthcare launches Vegzelma in US
South Korea's Celltrion Healthcare Co. on Monday said it launched on the US market Vegzelma, a biosimilar of Bevacizumab, a medication for colorecta...
Apr 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Biosimilar giant Celltrion to transform into drug developer
South Korean biosimilar giant Celltrion Group aims to transform into a drug developer by generating 40% of sales from new medicines by 2030 as it is...
Mar 29, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion founder returns to management with M&A pledge
South Korean biosimilar giant Celltrion Group’s founder Seo Jung-jin has returned to management two years after his departure, pledging to mer...
Mar 28, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion eyes Baxter's arm as it gears up for M&As
Celltrion Inc., South Korea’s largest biosimilar maker, said on Tuesday it has studied a possible acquisition of the biopharma solutions unit ...
Mar 21, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma wins $44 mn flu vaccine order from WHO agency
South Korea's pharmaceutical firm GC Biopharma Corp. said on Monday that it has won a $44.3 million (57.9 billion won) order for flu vaccines in a d...
Mar 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion, Genuv sign agreement for antibody joint R&D
South Korean biopharmaceutical firm Celltrion Inc. announced on Tuesday a joint research and development agreement with Genuv, Inc., a domestic drug...
Mar 14, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's licensed flu vaccine gets approval in Taiwan
South Korea's pharmaceutical firm GC Biopharma Corp. announced on Monday that its quadrivalent flu vaccine has received marketing approval from the ...
Mar 13, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma to develop mRNA flu vaccine with Canadian pharma
South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The dr...
Mar 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Phase 3 clinical plan for SK Bioscience's booster shot approved in Colombia
SK Bioscience Co., a leading South Korean vaccine and biotech company, announced on Monday that its phase 3 clinical trial plan for a heterogeneous ...
Mar 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion ex-Chairman Seo set to return to management; group stocks rally
South Korea’s biosimilar giant Celltrion Group’s founder and Honorary Chairman Seo Jung-jin is readying to return to management just two...
Mar 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion teams up with bio venture to develop new anti-cancer drug
South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's EuBiologics to receive support from Gates Foundation
South Korea's biopharmaceutical company EuBiologics Co. announced on Wednesday that its meningococcal pentavalent conjugate vaccine EuMCV5 under dev...
Feb 23, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma gets WHO pre-qualification approval for chickenpox vaccine
South Korea's GC Biopharma Corp. is set to regain the No. 1 spot in global production of chickenpox vaccines after earning qualification to enter th...
Feb 21, 2023 (Gmt+09:00)